The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
Open accessAbstract
// Feifei Cheng 1,2 , Li Su 1 and Cheng Qian 1 1 Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China 2 School of Life Science, Zhejiang Sci-Tech University, Hangzhou, China Correspondence to: Cheng Qian, email: // Keywords : liquid biopsy, circulating tumor DNA, biology, biomarker, targeted therapies Received : November 06, 2015 Accepted : April 24, 2016 Published : May 19, 2016 Abstract Tissue biopsy is the standard diagnostic procedure for cancers and also provides a material for genotyping, which can assist in the targeted therapies of cancers. However, tissue biopsy-based cancer diagnostic procedures have limitations in their assessment of cancer development, prognosis and genotyping, due to tumor heterogeneity and evolution. Circulating tumor DNA (ctDNA) is single- or double-stranded DNA released by the tumor cells into the blood and it thus harbors the mutations of the original tumor. In recent years, liquid biopsy based on ctDNA analysis has shed a new light on the molecular diagnosis and monitoring of cancer. Studies found that the screening of genetic mutations using ctDNA is highly sensitive and specific, suggesting that ctDNA analysis may significantly improve current systems of tumor diagnosis, even facilitating early-stage detection. Moreover, ctDNA analysis is capable of accurately determining the tumor progression, prognosis and assisting in targeted therapy. Therefore, using ctDNA as a liquid biopsy may herald a revolution for tumor management. Herein, we review the biology of ctDNA, its detection methods and potential applications in tumor diagnosis, treatment and prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774 · cited 2×
“For instance, the detection of early-stage tumor or residual lesions is unsatisfactory, and its application in the evaluation of treatment efficacy and prognosis is also limited [1-2].”
BackgroundAn Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
(1977) · PubMed · Cited by 1,801
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W. Y., Kaper, F., Dawson, S.-J., Piskorz, A. M., Jimenez-Linan, M., Bentley, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003726 · Cited by 1,297
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Löwer, M., Diekmann, J., Boegel, S., Schrörs, B., Vascotto, F., Castle, J. C., et al. (2015) · Nature · doi:10.1038/nature14426 · Cited by 1,243
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Non-Invasive Analysis of Acquired Resistance to Cancer Therapy By Sequencing of Plasma Dna
(2014) · Annals of Oncology · doi:10.1093/annonc/mdu312.5 · Cited by 1,169
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis
Kosaka, N., Iguchi, H., & Ochiya, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01650.x · Cited by 1,147
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., et al. (2015) · Nature Medicine · doi:10.1038/nm.3870 · Cited by 1,082
Circulating nucleic acids (CNAs) and cancer—A survey
Fleischhacker, M., & Schmidt, B. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.10.001 · Cited by 851
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
(15031584), Y. M. D. L., Chan, L. Y. S., Lo, K. W., Leung, S. F., Zhang, J., Chan, A. T. �., Lee, J. C., Hjelm, N. M., Johnson, P. J., & Huang, D. P. (1999) · PubMed · Cited by 777
About the possible origin and mechanism of circulating DNA
Stroun, M., Lyautey, J., Lederrey, C., Olson-Sand, A., & Anker, P. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00665-9 · Cited by 740
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Jiang, P., Chan, C. W. M., Chan, K. C. A., Cheng, S. H., Wong, J., Wong, V. W.-S., Wong, G. L. H., Chan, S. L., Mok, T. S. K., Chan, H. L. Y., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500076112 · Cited by 738
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Smith, C. C., Wang, Q., Chin, C.-S., Salerno, S., Damon, L. E., Levis, M. J., Perl, A. E., Travers, K. J., Wang, S., Hunt, J. P., et al. (2012) · Nature · doi:10.1038/nature11016 · Cited by 735
Tie, J., Kinde, I., Wang, Y., Wong, H. L., Roebert, J., Christie, M., Tacey, M., Wong, R., Singh, M., Karapetis, C. S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv177 · Cited by 635
Nanopore DNA sequencing with MspA
Derrington, I. M., Butler, T. Z., Collins, M. D., Manrao, E., Pavlenok, M., Niederweis, M., & Gundlach, J. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001831107 · Cited by 585
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
Sorenson, G. D., Pribish, D. M., Valone, F. H., Memoli, V. A., Bzik, D. J., & Yao, S. (1994) · PubMed · Cited by 530
Li, T., Kung, H.-J., Mack, P. C., & Gandara, D. R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3753 · Cited by 518
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Chan, K. A., Jiang, P., Zheng, Y. W., Liao, G. J., Sun, H., Wong, J., Siu, S. S. N., Chan, W. C., Chan, S. L., Chan, A. T., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.196014 · Cited by 488
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
Reinert, T., Schøler, L. V., Thomsen, R., Tobiasen, H., Vang, S., Nordentoft, I., Lamy, P., Kannerup, A.-S., Mortensen, F. V., Stribolt, K., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308859 · Cited by 463
Roschewski, M., Dunleavy, K., Pittaluga, S., Moorhead, M., Pepin, F., Kong, K., Shovlin, M., Jaffe, E. S., Staudt, L. M., Lai, C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)70106-3 · Cited by 463
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
Anker, P., Mulcahy, H., Qi Chen, X., & Stroun, M. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006260319913 · Cited by 451
Chan, K. C. A., Jiang, P., Chan, C. W. M., Sun, K., Wong, J., Hui, E. P., Chan, S. L., Chan, W. C., Hui, D. S. C., Ng, S. S. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313995110 · Cited by 447
Decoding long nanopore sequencing reads of natural DNA
Laszlo, A. H., Derrington, I. M., Ross, B. C., Brinkerhoff, H., Adey, A., Nova, I. C., Craig, J. M., Langford, K. W., Samson, J. M., Daza, R., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2950 · Cited by 443
Vasioukhin, V., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Stroun, M. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04828.x · Cited by 414
Yung, T. K. F., Chan, K. C. A., Mok, T. S. K., Tong, J., To, K.-F., & Lo, Y. M. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2622 · Cited by 385
Gray, E. S., Rizos, H., Reid, A. L., Boyd, S. C., Pereira, M. R., Lo, J., Tembe, V., Freeman, J., Lee, J. H. J., Scolyer, R. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5788 · Cited by 336
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Taniguchi, K., Uchida, J., Nishino, K., Kumagai, T., Okuyama, T., Okami, J., Higashiyama, M., Kodama, K., Imamura, F., & Kato, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1712 · Cited by 315
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Lebofsky, R., Decraene, C., Bernard, V., Kamal, M., Blin, A., Leroy, Q., Rio Frio, T., Pierron, G., Callens, C., Bieche, I., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.003 · Cited by 269
García-Olmo, D. C., Domínguez, C., García-Arranz, M., Anker, P., Stroun, M., García-Verdugo, J. M., & García-Olmo, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3513 · Cited by 267
Serum CA 19-9 as a Biomarker for Pancreatic Cancer—A Comprehensive Review
Ballehaninna, U. K., & Chamberlain, R. S. (2011) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-011-0042-1 · Cited by 240
Lipson, E. J., Velculescu, V. E., Pritchard, T. S., Sausen, M., Pardoll, D. M., Topalian, S. L., & Diaz, L. A. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-014-0042-0 · Cited by 217
Circulating Tumor Cells: A Multifunctional Biomarker
Yap, T. A., Lorente, D., Omlin, A., Olmos, D., & de Bono, J. S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2664 · Cited by 206
Bidard, F., Madic, J., Mariani, P., Piperno‐Neumann, S., Rampanou, A., Servois, V., Cassoux, N., Desjardins, L., Milder, M., Vaucher, I., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28436 · Cited by 201
Qiu, M., Wang, J., Xu, Y., Ding, X., Li, M., Jiang, F., Xu, L., & Yin, R. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0895 · Cited by 188
Diamandis, E. P. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-87 · Cited by 185
Ilié, M., Hofman, V., Long-Mira, É., Bordone, O., Selva, É., Washetine, K., Marquette, C., & Hofman, V. (2014) · PubMed · doi:10.3978/j.issn.2305-5839.2014.08.11 · Cited by 175
Chang-Hao Tsao, S., Weiss, J., Hudson, C., Christophi, C., Cebon, J., Behren, A., & Dobrovic, A. (2015) · Scientific Reports · doi:10.1038/srep11198 · Cited by 173
Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma
Chan, K. C. A., Lai, P. B. S., Mok, T. S. K., Chan, H. L. Y., Ding, C., Yeung, S. W., & Lo, Y. M. D. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.104653 · Cited by 170
The Origin of Circulating Free DNA
van der Vaart, M., & Pretorius, P. J. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.092734 · Cited by 167
Cancer biomarkers: Written in blood
Yong, E. (2014) · Nature · doi:10.1038/511524a · Cited by 165
Chan, K. C. A., Hung, E. C. W., Woo, J. K. S., Chan, P. K. S., Leung, S., Lai, F. P. T., Cheng, A. S. M., Yeung, S. W., Chan, Y. W., Tsui, T. K. C., et al. (2013) · Cancer · doi:10.1002/cncr.28001 · Cited by 163
Madhavan, D., Wallwiener, M., Bents, K., Zucknick, M., Nees, J., Schott, S., Cuk, K., Riethdorf, S., Trumpp, A., Pantel, K., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2946-2 · Cited by 161
He, C.-Z., Zhang, K.-H., Li, Q., Liu, X.-H., Hong, Y., & Lv, N.-H. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-87 · Cited by 161
Circulating tumor-derived DNA is shorter than somatic DNA in plasma
Mouliere, F., & Rosenfeld, N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501321112 · Cited by 160
Clinical Relevance of Circulating Nucleosomes in Cancer
Holdenrieder, S., Nagel, D., Schalhorn, A., Heinemann, V., Wilkowski, R., von Pawel, J., Raith, H., Feldmann, K., Kremer, A. E., Müller, S., et al. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.012 · Cited by 148
Cancer biomarker discovery: Current status and future perspectives
Mäbert, K., Cojoc, M., Peitzsch, C., Kurth, I., Souchelnytskyi, S., & Dubrovska, A. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892229 · Cited by 139
The virtosome—a novel cytosolic informative entity and intercellular messenger
Gahan, P. B., & Stroun, M. (2010) · Cell Biochemistry and Function · doi:10.1002/cbf.1690 · Cited by 136
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Anker, P., Herrera‐Goepfert, R., Medina-Velázquez, L. A., Hidalgo‐Miranda, A., Pérez‐Montiel, D., Chávez-Blanco, A. D., Cruz, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052754 · Cited by 134
The emergence of nanopores in next-generation sequencing
Steinbock, L. J., & Rađenović, A. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/7/074003 · Cited by 119
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA
Chaudhuri, A. A., Binkley, M. S., Osmundson, E. C., Alizadeh, A. A., & Diehn, M. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.001 · Cited by 118
Garcı́a-Olmo, D. C., Dc, G.-O., Ontañón, J., Martinez, E., & Vallejo, M. (1999) · PubMed · doi:10.14670/hh-14.1159 · Cited by 114
Freidin, M. B., Freydin, M., Leung, M., Montero, Á., Nicholson, A. G., & Lim, E. K. S. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.242453 · Cited by 113
CEA Serum Levels in Non-Neoplastic Disease
Morell, Á. R. (1992) · The International Journal of Biological Markers · doi:10.1177/172460089200700307 · Cited by 108
Monitoring gastric cancer progression with circulating tumour DNA
Hamakawa, T., Kukita, Y., Kurokawa, Y., Miyazaki, Y., Takahashi, T., Yamasaki, M., Miyata, H., Nakajima, K., Taniguchi, K., Takiguchi, S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.609 · Cited by 105
Campitelli, M., Jeannot, E., Peter, M., Lappartient, E., Saada, S., de la Rochefordière, A., Fourchotte, V., Alran, S., Petrow, P. K., Cottu, P. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043393 · Cited by 102
Kidess, E., Heirich, K., Wiggin, M., Vysotskaia, V. S., Visser, B. C., Marziali, A., Wiedenmann, B., Norton, J. A., Lee, M., Jeffrey, S. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3041 · Cited by 100
Boesch, M., Zeimet, A. G., Reimer, D., Schmidt, S. U., Gastl, G. A., Parson, W., Spoeck, F., Hatina, J., Wolf, D. G. F., & Sopper, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2053 · Cited by 94
Circulating miR-148b and miR-133a as biomarkers for breast cancer detection
Shen, J., Hu, Q., Schrauder, M. G., Yan, L., Wang, D., Medico, L., Guo, Y., Yao, S., Zhu, Q., Liu, B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2014 · Cited by 87
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Jiang, T., Ren, S., & Zhou, C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.013 · Cited by 86
Balgkouranidou, I., Chimonidou, M., Milaki, G., Tsarouxa, E. G., Kakolyris, S., Welch, D. R., Georgoulias, V., & Lianidou, E. S. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.104 · Cited by 85
Increased integrity of circulating cell-free DNA in plasma of patients with acute leukemia
Gao, Y., He, Y., Yang, Z., Shao, H.-Y., Zuo, Y., Bai, Y., Chen, H., Chen, X., Qin, F., Tan, S., et al. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.311 · Cited by 82
Han, S., Zhou, X., Sui, X. Y., He, C., Cai, M., Ma, J., Zhang, Y., Zhou, C., Ma, C.-X., Varela-Ramírez, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4529 · Cited by 78
Functionality of Circulating DNA
García‐Olmo, D., & GARCÍA‐OLMO, D. C. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03895.x · Cited by 74
Martignetti, J. A., Camacho‐Vanegas, O., Priedigkeit, N., Camacho, C., Pereira, E. B., Li, L., Garnar-Wortzel, L., Miller, D., Losic, B., Shah, H., et al. (2014) · Neoplasia · doi:10.1593/neo.131900 · Cited by 62
Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer
Nie, K., Jia, Y., & Zhang, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2758-3 · Cited by 61
Han, S., Wang, J.-L., Guo, X.-J., He, C., Ying, X., Ma, J., Zhang, Y., Zhao, Q. C., & Zhu, Q. (2014) · Journal of Immunology Research · doi:10.1155/2014/262385 · Cited by 50
Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
Huh, W. K., Williams, E., Huang, J., Bramley, T., & Poulios, N. (2014) · Applied Health Economics and Health Policy · doi:10.1007/s40258-014-0135-4 · Cited by 45
Biological Role of Cell-Free Nucleic Acids in Cancer: The Theory of Genometastasis
Garcı́a-Olmo, D. C., & García‐Olmo, D. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.90 · Cited by 36
Prostate tissue and serum markers.
Mazzucchelli, R., Colanzi, P., Pomante, R., et al. (2000) · PubMed · Cited by 34
Detection of circulating tumor cells and of tumor DNA in plasma during tumor progression in rats
Garcı́a-Olmo, D. C., Gutiérrez-González, L., Ruiz-Piqueras, R., Picazo, M. G., & García‐Olmo, D. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.043 · Cited by 32
Novel molecular insights from routine genotyping of colorectal carcinomas
Stachler, M. D., Rinehart, E. M., Lindeman, N. I., Odze, R. D., & Srivastava, A. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.01.005 · Cited by 26
Next-generation sequencing in precision oncology: challenges and opportunities
Kruglyak, K. M., Lin, E., & Ong, F. S.-C. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.916213 · Cited by 25
Garcı́a-Olmo, D. C., Gutiérrez-González, L., Samos, J., Picazo, M. G., Atiénzar, M., & García‐Olmo, D. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.05.032 · Cited by 17
Cited by
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedAhmad, A., Imran, M., & Ahsan, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061630 · Cited by 386
ctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 298
FGFR-TKI resistance in cancer: current status and perspectives
Yue, S., Li, Y., Chen, X., Wang, J., Li, M., Chen, Y., & Wu, D. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01040-2 · Cited by 145
Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy
Wang, X., Wang, L., Lin, H., Zhu, Y., Huang, D., Lai, M., Xi, X., Huang, J., Zhang, W., & Zhong, T. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1303335 · Cited by 112
Metadata
- Authors
- Cheng, F., Su, L., & Qian, C.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-05-19
- Volume
- 7
- Issue
- 30
- Pages
- 48832-48841
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2402146695
- Cited by
- 406
- References
- 92
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.